All In Biotech

Drug Trial Radar · NCT04739293

Study of ON 123300 in Patients With Advanced Cancer

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ON 123300 Capsules Administered Orally as Escalating Daily Doses in Patients With Advanced Cancer Relapsed or Refractory to at Least One (1) Prior Line of Therapy

Last checked: Nov 19, 2026Latest source record: Dec 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

36

Planned (sponsor's estimate)

Start

May 13, 2021

Primary completion

Oct 2024

Study completion Oct 2024

Sponsor

Lead sponsor
Traws Pharma, Inc.Industry
Sponsor type
Industry
First posted
Feb 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will investigate the safety of the drug ON 123300 at increasing doses to determine the best dose to use in future clinical trials.

Conditions

  • Solid Tumors, Adult

Interventions

  • ON123300Drug

    ON 123300 hard gelatin capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Dose Limiting Toxicities (DLT)Time frame: First 28 days of dosing
  2. Incidence of adverse events (AE)Time frame: Consent to 30 days after last dose
  3. Abnormal Laboratory Test resultsTime frame: Consent to 30 days after last dose

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • START Midwest

    Grand Rapids, Michigan · Recruiting

  • Greenville Health System, Institute for Oncology Clinical Research

    Greenville, South Carolina · Recruiting

  • Mary Crowley Cancer Research

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.